top of page
Executive Spotlights

Moderna to buy Japan-based OriCiro Genomics for US $85M

Cambridge, MA, January 4, 2023 (Proactive Investors) -- Moderna Inc, the biotech pioneering messenger RNA (mRNA) therapeutics and vaccines, said it has struck a deal to buy Japan-based OriCiro Genomics for US$85 million to boost its manufacturing capabilities.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Комментарии


Life Science Headlines
bottom of page